Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | 4:持股变动声明-董事 SEKHRI PAUL J
Longboard Pharmaceuticals | 4:持股变动声明-董事 SCHNEIDER PHILLIP M
Longboard Pharmaceuticals | 4:持股变动声明-董事 Lynch Casey
Longboard Pharmaceuticals | 4:持股变动声明-董事 Le Goff Corinne
Longboard Pharmaceuticals | 4:持股变动声明-董事 Aurentz Vincent
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | 10-Q:季度报表
Longboard Pharmaceuticals | 8-K:Longboard Pharmicals公布2024年第一季度财务业绩并提供公司最新情况
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | ARS:年度报告
Longboard Pharmaceuticals | DEFA14A:其他
Longboard Pharmaceuticals | DEF 14A:股东委托书决议
Longboard Pharmaceuticals | PRE 14A:并购重组委托声明
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | S-8:员工福利计划证券登记
Longboard Pharmaceuticals | S-3ASR:“知名成熟发行人”证券注册声明
Longboard Pharmaceuticals | 10-K:年度报表
Longboard Pharmaceuticals | 8-K:重大事件
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.749%),Abigail P. Johnson(12.749%)
暂无数据